Safety and Effectiveness of Kovacaine Nasal Spray for Dental Anesthesia

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Dental Anesthesia Efficacy
Interventions
DRUG

3% tetracaine HCL with 0.05% oxymetazoline HCL

1 sham injection along with 3 sprays of Kovacaine Nasal Spray in each nostril; a 4-minute interval between every set of sprays. The total dose of 3% tetracaine HCL with 0.05% oxymetazoline HCL was 18 mg/0.3 mg.

DRUG

Lidocaine Injection

Each subject received both an injection along with 3 sprays of isotonic saline sham in each nostril; a 4-minute interval between every set of sprays.

Trial Locations (1)

Unknown

University of Buffalo, Buffalo

Sponsors
All Listed Sponsors
collaborator

Ground Zero Pharmaceuticals

INDUSTRY

collaborator

Rho, Inc.

INDUSTRY

lead

St. Renatus, LLC

INDUSTRY